查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424358

按组成部分、癌症类型、治疗类型、最终用户和地区分類的肿瘤学人工智慧 (AI) 的全球市场

Global Artificial Intelligence in Oncology Market, By Component, By Cancer Type, By Treatment Type, By End User, By Region
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

肿瘤学领域人工智慧 (AI) 的全球市场规模预计将从 2023 年的 12 亿美元增加到 2030 年的 91.642 亿美元，预测期内复合年增长率为 33.7%。

报告范围 报告详情
基准年 2022年 2023/2024年市场规模 12亿美元
实际资料 2018-2021 预测期 2023-2030
预测期间 2023/2024 至 2030/2031 年复合年增长率： 33.70% 2030/2031 年预测值 91.642 亿美元
图 1. 2023 年按地区分類的肿瘤学领域人工智慧 (AI) 的全球市场占有率(%)
全球肿瘤市场人工智慧-IMG1

人工智慧（AI）在肿瘤学中发挥重要作用。有不同类型的人工智慧产品可以帮助癌症筛检、诊断、治疗和药物开发。我们的主要产品之一是人工智慧辅助的癌症筛检工具。这些工具使用在庞大的医学影像资料库上训练的深度学习演算法。它可以帮助医生检测 CT、MRI 和乳房 X 光检查等扫描影像中的异常情况。它可以快速分析大量图像，并突出显示医生仅透过人工筛检可能会错过的可疑区域。这提高了早期肿瘤检测的准确性并增加了挽救的生命数量。然而，随着时间的推移改进演算法需要不断更新新资料。还有误诊的风险，因为人工智慧可能无法有效区分罕见的癌症类型。

其他重要应用包括人工智慧在癌症诊断、预后和治疗的应用。透过对大量基因组和临床资料集进行机器学习，人工智慧可以识别复杂的模式，获得新的见解，并比人类更好地预测治疗反应。这有助于客製化标靶治疗。人工智慧还透过帮助识别标靶、筛检化合物和优化临床试验来加速药物开发。

市场动态：

癌症发生率上升和癌症治疗决策日益复杂是推动肿瘤学中采用人工智慧解决方案的关键因素。数位健康资料和运算能力的不断增加正在推动先进人工智慧技术的发展。然而，开发高精度、临床级人工智慧解决方案所需的高投资和成本是一个主要抑制因素。此外，缺乏对人工智慧所做决策的解释和理解也限制了普及。另一方面，人工智慧透过实现个人化治疗方法选择来帮助克服抗药性的潜力提供了机会。科技公司与研究机构的合作旨在进一步检验人工智慧的临床应用潜力。

按地区划分，北美由于医疗费用高且获得良好的医疗服务而占据市场主导地位。然而，在中国和印度等国家的推动下，亚太地区是成长最快的市场。这种成长是由于经济成长、可支配收入增加、医疗基础设施扩大以及技术先进的癌症诊断工具的更多采用。

本研究的主要特点

  • 本报告对全球肿瘤人工智慧（AI）市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030）的市场规模和复合年增长率。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球肿瘤学市场人工智慧 (AI)的主要企业。
  • 该报告的见解将使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 肿瘤学人工智慧 (AI) 全球市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球肿瘤学人工智慧 (AI) 市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第 3 章 重要产业洞察

  • 市场动态
  • 促进因素
  • 抑制因素
  • 机会
  • 影响分析
  • PEST分析
  • 波特的分析
  • 技术进步
  • 合併、收购和合作场景
  • 最近的产品核准/发布
  • 公司市场占有率分析

第 4 章 2018-2030 年肿瘤学人工智慧 (AI) 市场（按组件类型）

  • 软体解决方案
  • 硬体
  • 服务

第 5 章 2018-2030 年肿瘤学人工智慧 (AI) 市场（按癌症类型）

  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 大肠直肠癌
  • 脑肿瘤
  • 其他的

第 6 章 2018-2030 年肿瘤学人工智慧 (AI) 市场（按治疗类型）

  • 化疗
  • 放射治疗
  • 免疫疗法
  • 其他的

第七章 2018-2030 年肿瘤学人工智慧 (AI) 市场（按地区）

  • 按地区
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第八章公司简介-肿瘤学人工智慧（AI）市场

  • NVIDIA Corporation
    • 公司简介
    • 产品/服务组合
    • 财务绩效
    • 最新动态/最新讯息
    • 策略概览
  • Digital Diagnostics Inc.
  • ConcertAI
  • Median Technologies
  • PathAI
  • Azra AI
  • IBM
  • Siemens Healthcare GmbH

第9章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI6509

The global artificial intelligence in oncology market size is expected to reach US$ 9,164.2 Mn by 2030, from US$ 1,200 Mn in 2023, at a CAGR of 33.7% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 1,200 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 33.70% 2030/2031 Value Projection: US$ 9,164.2 Mn
Figure 1. Global Artificial Intelligence in Oncology Market Share (%), by Region, 2023
Global Artificial Intelligence in Oncology Market - IMG1

Artificial intelligence (AI) plays an important role in oncology. There are various types of AI products that are helping in cancer screening, diagnosis, treatment, and drug development. One of the major products is an AI-assisted cancer screening tool. These tools use deep learning algorithms that have been trained on huge databases of medical images. They help physicians detect abnormalities in scans like CT, MRI, or mammograms. They can rapidly analyze a large number of images and highlight suspect areas that the doctor may miss with human screening alone. This improves the accuracy of detecting tumors at early stages and increases the number of lives saved. However, the algorithms need continuous updates with new data to improve over time. Misdiagnosis is also a risk because the AI may not be able to distinguish rare cancer types effectively.

Other important applications include the use of AI in cancer diagnostics, prognosis, and therapeutics. Using machine learning on vast pools of genomic and clinical cancer datasets, AI can recognize complex patterns, emerge with new insights, and predict treatment responses better than humans. This helps with customized and targeted therapy. AI is also speeding up drug development by assisting in target identification, compound screening, and clinical trial optimization.

Market Dynamics:

Rising cancer incidence coupled with the increasing complexity of cancer treatment decisions is a key factor driving the adoption of AI solutions in oncology. The growing availability of digital health data and computational power is facilitating the development of advanced AI technologies. However, the high investment and costs required for the development of precision and clinical-grade AI solutions are a major restraint. Lack of interpretability and understanding of how AI arrives at its decisions also limits widespread adoption. Meanwhile, the potential of AI to help overcome drug resistance by enabling personalized treatment selection presents an opportunity. Partnerships between technology companies and research institutes aim to further validate the clinical applicability of AI.

Among regions, North America dominates the market due to high healthcare expenditures and better access to care. However, Asia Pacific is poised to be the fastest-growing market arena, led by countries like China and India. This growth can be attributed to growing economies, rising disposable incomes, expanding medical infrastructure, and the increasing adoption of technologically advanced cancer diagnostic tools.

Key features of the study:

  • This report provides in-depth analysis of the global artificial intelligence in oncology market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global artificial intelligence in oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Azra AI, IBM Corporation, Siemens Healthineers AG, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI, Median Technologies, PathAI, Microsoft, Zebra Medical Vision, and Babylon
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global artificial intelligence in oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in oncology market

Global Artificial Intelligence in Oncology Market Segmentation:

  • By Component
    • Software/Platform
    • Hardware
    • Services
  • By Cancer Type
    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Brain Tumor
    • Others
  • By Treatment Type
    • Chemotherapy
    • Radiotherapy
    • Immunotherapy
    • Others
  • By End User:
    • Hospitals & Clinics
    • Diagnostic Centers
    • Biopharmaceutical Companies
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top companies in Global Artificial Intelligence in Oncology Market:
    • Azra AI
    • IBm Corporation
    • Siemens Healthineers AG
    • Intel Corporation
    • GE HealthCare
    • NVIDIA Corporation
    • Digital Diagnostics Inc.
    • ConcertAI
    • Median Technologies
    • PathAI
    • Microsoft
    • Zebra Medical Vision
    • Babylon

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Top 3 Market Findings
    • Top 3 Market Opportunity

3. Key Industry Insights

  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancement
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals/Launches
  • Company Market Share Analysis

4. Artificial Intelligence In Oncology Market, By Component Type, 2018 - 2030 ( US$ Million)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
    • Segment Trends
  • Software Solutions, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Hardware, 2018 - 2030( US$ Million
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Services, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)

5. Artificial Intelligence In Oncology Market, By Cancer Type, 2018 - 2030 ( US$ Million)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
    • Segment Trends
  • Breast Cancer, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Lung Cancer, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Prostate Cancer, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Colorectal Cancer, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Brain Tumor, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Others, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)

6. Artificial Intelligence In Oncology Market, By Treatment Type, 2018 - 2030 ( US$ Million)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
    • Segment Trends
  • Chemotherapy, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Radiotherapy, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Immunotherapy, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Others, 2018 - 2030( US$ Million)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)

7. Artificial Intelligence In Oncology Market, By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 - 2030, ( US$ Million)
    • Segment Trends
  • By Region
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • North America
    • Introduction
    • Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
  • U.S.
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Canada
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Europe
    • Introduction
    • Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
  • U.K
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Germany
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • France
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Italy
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Spain
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Russia
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Rest of Europe
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
  • China
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • India
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Japan
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Australia
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • South Korea
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • ASEAN
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Rest of Asia Pacific
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Latin America
    • Introduction
    • Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
  • Brazil
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Mexico
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Argentina
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Rest of Latin America
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Middle East
    • Introduction
    • Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
  • GCC
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Israel
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Rest of Middle East
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Africa
    • Introduction
    • Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
  • North Africa
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • Central Africa
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)
  • South Africa
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Million)

8. Company Profiles - Artificial Intelligence In Oncology Market

  • NVIDIA Corporation*
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Digital Diagnostics Inc.
  • ConcertAI
  • Median Technologies
  • PathAI
  • Azra AI
  • IBM
  • Siemens Healthcare GmbH

9. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact